⏳ Fetching live dividend data...
Home › Calculator › SPHS Dividend Calculator 2026
Sophiris Bio, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SPHS → $3.602881501577331e+74M in 10 years · $30,024,012,498,484,260,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
Sophiris Bio, Inc. is a biopharmaceutical entity currently in the clinical trial phase, dedicated to pioneering treatments for conditions affecting the urinary system. Its flagship investigational compound, PRX302 (topsalysin), is presently undergoing Phase III trials. This candidate is being evaluated for its efficacy in alleviating lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) and for addressing localized low to intermediate risk prostate cancer. Sophiris has forged a strategic alliance with Kissei Pharmaceutical Co., Ltd. This collaboration encompasses the development and commercialization of PRX302 for a range of prostatic ailments, including BPH symptoms, prostate cancer, and prostatitis. Furthermore, the company holds licensing rights from UVIC Industry Partnerships Inc. and The Johns Hopkins University. These agreements pertain to the application of PRX302 in developing therapies for BPH symptoms, prostate cancer, and various other non-malignant prostate conditions. Originally established in 2002, the company operated as Protox Therapeutics Inc. before adopting the Sophiris Bio, Inc. name in April 2012. Its operations are headquartered in La Jolla, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SPHS position with:
Real after-tax yield depends on where you live and how you hold SPHS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 200000000.00% | 199999997.20% | $20,000,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 170000000.00% | 169999997.20% | $17,000,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 160000000.00% | 159999997.20% | $16,000,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 200000000.00% | 199999997.20% | $20,000,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 182500000.00% | 182499997.20% | $18,250,000,000 / yr |
| 🇨🇦 TFSA | 0% | 200000000.00% | 199999997.20% | $20,000,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 150000000.00% | 149999997.20% | $15,000,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 170000000.00% | 169999997.20% | $17,000,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 140000000.00% | 139999997.20% | $14,000,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 147250000.00% | 147249997.20% | $14,725,000,000 / yr |
| 🇫🇷 FR Taxable | 30% | 140000000.00% | 139999997.20% | $14,000,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
SPHS pays quarterly — 4 times per year. Next ex-div: TBD.
How SPHS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SPHS sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2019-12-19 | 123,000 | $0.36 | $44.3K | ||
| A-Award | 2019-06-27 | 20,000 | $0.78 | $15.6K | ||
| A-Award | 2019-06-27 | 20,000 | $0.78 | $15.6K | ||
| A-Award | 2019-06-27 | 20,000 | $0.78 | $15.6K | ||
| A-Award | 2018-12-31 | 245,000 | $0.83 | $203.3K | ||
| A-Award | 2018-06-27 | 20,000 | $2.91 | $58.2K | ||
| A-Award | 2018-06-27 | 20,000 | $2.91 | $58.2K | ||
| A-Award | 2018-06-27 | 20,000 | $2.91 | $58.2K | ||
| A-Award | 2017-12-06 | 8,000 | $1.91 | $15.3K | ||
| A-Award | 2017-05-30 | 20,000 | $2.44 | $48.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SPHS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →